Clinicien(ne) chercheur(e)

Dr Jean Champagne

Cardiologie

jean.champagne@criucpq.ulaval.ca

Domaine de recherche

Arythmie cardiaque.

Description des travaux

Le Dr Jean Champagne est actuellement cardiologue et électrophysiologiste à l'Institut de cardiologie de Québec. Il est également professeur agrégé de clinique à l'Université Laval. Après sa formation en cardiologie en 1995, il a effectué deux années supplémentaires de fellowship en électrophysiologie incluant une année en Belgique avec le professeur Pedro Brugada. Il a participé à plus de 60 communications scientifiques nationales et internationales, incluant 30 comme 1e auteur. Son expertise actuellement porte principalement sur l'investigation des fibrillations ventriculaires idiopathiques incluant le syndrome de Brugada et sur l'ablation primaire de la fibrillation auriculaire. Il participe activement à l'évaluation des nouvelles technologies surtout concernant l'efficacité des cardio-défibrillateurs biventriculaires utile dans l'insuffisance cardiaque.

Prix et distinctions

Lors du congrès Eighth international workshop on cardiac arrhythmias 2003, qui a eu lieu à Venise, Italie, le résumé intitulé : Prevalence, prognostic and electrocardiographic patterns of the Brugada syndrome in the Quebec Cardiovascular Study, a été choisi par le comité scientifique comme la meilleure communication parmi plus de 250 résumés présentés au congrès
Examinateur en cardiologie pour le Collège royal des médecins et chirurgiens du Canada (2003-à ce jour) Vice-président de la Société de cardiologie de Québec (éducation médicale continue), (2006 à ce jour) Abstract reviewer pour la section électrophysiologie cardiaque du congrès canadien de cardiologie de 2005.

Publications

135

Trier par année :

Champagne J, Poirier P, Dumesnil JG, Desaulniers D, Boudreault JR, O'Hara G, Gilbert M, Philippon F. Permanent pacemaker lead entrapment: role of the transesophageal echocardiography. Pacing Clin Electrophysiol 2002; 25(7):1131-4.
Champagne J, Poirier P, O'Hara G, Gilbert M, Soucy B, Philippon F. Differential effect of right and left carotid sinus massage: implications for sudden rate drop pacing algorithm.. Can J Cardiol 2002; 18(7):763-7.
Déry JP, Gilbert M, O'Hara G, Champagne J, Desaulniers D, Cartier P, Philippon F. Pacemaker contact sensitivity: case report and review of the literature.. Pacing Clin Electrophysiol 2002; 25(5):863-5.
Champagne J, Geelen P, Philippon F, Brugada P. Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome.. BMC Med 2005; 3(1):1.
Plante I, Fournier D, Ricard G, Drolet B, O'Hara G, Champagne J, Mathieu P, Baillot R, Daleau P. Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.. Pflugers Arch 2006; 452(3):316-23.
Huang H, Zhao J, Barrane FZ, Champagne J, Chahine M. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.. Can J Cardiol 2006; 22(4):309-13.
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial.. JAMA 2006; 295(2):165-71.
O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Philippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rh. Am J Cardiol 2005; 96(6):815-21.
Gould P, Champagne J, Krawn A: the Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories: a report from the Canadian Heart Rhythm Society working group on device advisories.. JAMA 2006; 295(16):1907-11.
Champagne J, Echahidi N, Philippon F, St-Pierre A, Molin F, Blier L, Gilbert M, Villeneuve J, Mohty D, O'Hara G. Usefulness of transesophageal echocardiography in the isolation of pulmonary veins in the treatment of atrial fibrillation.. Pacing Clin Electrophysiol 2007; 30(0):S116-9.
Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.. Circulation 2006; 114(2):104-9.
Echahidi N, Philippon F, O'Hara G, Champagne J. Life-Threatening Left Atrial Wall Hematoma Secondary to a Pulmonary Vein Laceration: An Unusual Complication of Catheter Ablation for Atrial Fibrillation.. J Cardiovasc Electrophysiol 2008; 19(5):556-8.
Echahidi N, Mohty D, Pibarot P, Després JP, O'Hara G, Champagne J, Philippon F, Daleau P, Voisine P, Mathieu P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.. Circulation 2007; 116(11):I213-9.
Champagne J, Philippon F, Gilbert M, Molin F, Blier L, Nault I, Sarrazin JF, Charbonneau L, Dufort L, Drolet B, Chahine M, OHara GE. The Brugada Syndrome in Canada: A Unique French Canadian Experience.. Can J Cardiol 2007; 23(0):71-75B.
OHara GE, Philippon F, Champagne J, Blier L, Molin F, Côté JM, Nault I, Sarrazin JF, Gilbert M. Catheter ablation for cardiac arrhythmias: A 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital.. Can J Cardiol 2007; 23(0):67-70B.
Chrestian N, Valdmanis PN, Echahidi N, Brunet D, Gould P, Rouleau GA, Champagne J, Dupré N. A Novel Mutation in a French-Canadian Family with LGMD1B.. Can J Neurol Sci 2008; 35(0):331-334.
Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Esseba. Outcome of the Fidelis Implantable Cardioverter-Defibrillator Lead Advisory: a report from the Canadian Heart Rhythm Society Working Group on Device Advisories.. Heart Rhythm 2008; 5(5):639-42.
Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA. Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee.. Heart Rhythm 2009; 6(4):474-7.
Gould PA, Gula LJ, Champagne J, Healey JS, Cameron D, Simpson C, Thibault B, Pinter A, Tung S, Sterns L, Birnie D, Exner D, Parkash R, Skanes AC, Yee R, Klein GJ, Krahn AD. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up.. Heart Rhythm 2008; 5(12):1675-81.
Nault I, O'Hara G, Philippon F, Larose É, Molin F, Blier L, Gilbert M, Champagne J. Long term follow-up after atrioventricular node ablation and right ventricular pacing: effects on clinical events and left ventricular function. Pacing Clin Electrophysiol 2008; 1(0):1-6.
Sénéchal M, Lancelloti P, Garceau P, Champagne J, Dubois M, Magne J, Blier L, Molin F, Philippon F, Dumesnil JG, Pierard L, O'Hara G. Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.. Echocardiography 2010; 27(1):50-7.
Magne J, Dubois M, Champagne J, Dumesnil JG, Pibarot P, Philippon F, O'Hara G, Sénéchal M.. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.. Cardiovasc Ultrasound 2009; 7(1):39.
Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Essebag V, Gardner M. Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.. Can J Cardiol 2009; 25(7):403-5.
Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J, Gardner M, Sanatani S, Exner DV, Klein GJ, Yee R, Skanes AC, Gula LJ, Gollob MH. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER).. Circulation 2009; 120(4):278-85.
Khaykin Y, Skanes A, Champagne J, Themistoclakis S, Gula L, Rossillo A, Bonso A, Raviele A, Morillo CA, Verma A, Wulffhart Z, Martin DO, Natale A. A randomized controlled trial of the efficacy and safety of electroanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasound.. Circ Arrhythm Electrophysiol 2009; 2(5):481-7.
Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Blier L, Molin F, Philippon F, Marie M, O'Hara G, Dubois M. Contractile Reserve Assessed Using Dobutamine Echocardiography Predicts Left Ventricular Reverse Remodeling after Cardiac Resynchronization Therapy: Prospective Validation in Patients with Left Ventricular Dyssynchrony.. Echocardiography 2010; 27(6):668-76.
Gollob MH, Blier L, Brugada R, Champagne J, Chauhan V, Connors S, Gardner M, Green MS, Gow R, Hamilton R, Harris L, Healey JS, Hodgkinson K, Honeywell C, Kantoch M, Kirsh J, Krahn A, Mullen M, Parkash R, Redfearn D, Rutberg J, Sanatani S, Woo A. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: canadian cardiovascular society/canadian heart rhythm society joint position paper.. Can J Cardiol 2011; 27(2):232-45.
Fromentin S, Sarrazin JF, Champagne J, Nault I, Philippon F, Molin F, Blier L, O'Hara G. Prospective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energy.. J Interv Card Electrophysiol 2011; 31(3):237-42.
Rodés-Cabau J, Champagne J, Bernier M. Transcatheter closure of the left atrial appendage: initial experience with the Amplatzer cardiac plug device.. Catheter Cardiovasc Interv 2010; 76(2):186-92.
Verma A, Sanders P, Macle L, Champagne J, Nair GM, Calkins H, Wilber DJ. Selective CFAE Targeting for Atrial Fibrillation Study (SELECT AF): Clinical Rationale, Design, and Implementation.. J Cardiovasc Electrophysiol 2011; 22(5):541-7.
Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Philippon F, O'Hara G, Moonen M, Dubois M. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.. Am J Cardiol 2010; 106(1):31-7.
Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee.. Circulation 2010; 121(22):2384-7.
O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J. Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ-PAF Study.. J Clin Pharmacol 2011; 0(0):Epub.
Patoine D, Hasibu I, Pilote S, Champagne J, Drolet B, Simard C. A Novel KCNQ1 Variant (L203P) Associated with Torsades de Pointes-Related Syncope in a Steinert Syndrome Patient.. Can J Cardiol 2011; 27(2):263.e5-263.e12.
Champagne J, Healey JS, Krahn AD, Philippon F, Gurevitz O, Swearingen A, Glikson M, . The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation.. Europace 2011; 13(3):409-15.
Derval N, Simpson CS, Birnie DH, Healey JS, Chauhan V, Champagne J, Gardner M, Sanatani S, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Ahmad K, Gollob MH, Haïssaguerre M, Klein GJ, Krahn AD. Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry.. J Am Coll Cardiol 2011; 58(7):722-8.
Krahn AD, Healey JS, Simpson CS, Chauhan VS, Birnie DH, Champagne J, Gardner M, Sanatani S, Chakrabarti S, Yee R, Skanes AC, Leong-Sit P, Ahmad K, Gollob MH, Klein GJ, Gula LJ, Sheldon RS. Sentinel symptoms in patients with unexplained cardiac arrest: from the cardiac arrest survivors with preserved ejection fraction registry (CASPER).. J Cardiovasc Electrophysiol 2012; 23(1):60-6.
Essebag V, Champagne J, Birnie DH, Verma A, Healey JS, Simpson CS, Kus T, Thibault B, Mangat I, Tung S, Sterns L, Exner DV, Davies T, Coutu B, Crystal E, Stephenson EA, Connors S, Paredes FA, Parkash R, Krahn AD. Nonphysiologic noise early after defibrillator implantation in Canada: incidence and implications: a report from the Canadian Heart Rhythm Society Device Committee.. Heart Rhythm 2012; 9(3):378-82.
Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Response to Letter Regarding Article, Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee. Circulation 2011; 123(0):E376-7.
Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial.. J Am Coll Cardiol 2013; 61(16):1713-23.
Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo CA, Khaykin Y, Birnie D. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.. JAMA Intern Med 2013; 173(2):149-56.
Mardigyan V, Verma A, Birnie D, Guerra P, Redfearn D, Becker G, Champagne J, Sapp J, Gula L, Parkash R, Macle L, Crystal E, O'Hara G, Khaykin Y, Sturmer M, Veenhuyzen GD, Greiss I, Sarrazin JF, Mangat I, Novak P, Skanes A, Roux JF, Chauhan V, Hadjis T, Morillo CA, Essebag V. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.. Can J Cardiol 2013; 29(2):219-23.
Steinberg C, Sarrazin JF, Philippon F, Bouchard MA, O'Hara G, Molin F, Nault I, Blier L, Champagne J. Detection of high incidence of Riata lead breaches by systematic postero-anterior and lateral chest X-ray in a large cohort.. Europace 2013; 15(3):402-8.
Steinberg C, Pelletier MJ, Champagne J. Complete absence of precordial R waves due to absence of left-sided pericardium.. Ann Noninvasive Electrocardiol 2012; 17(4):401-4.
Krahn AD, Healey JS, Chauhan VS, Birnie DH, Champagne J, Sanatani S, Ahmad K, Ballantyne E, Gerull B, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Klein GJ, Gollob MH, Simpson CS, Talajic M, Gardner M. Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry.. Circ Arrhythm Electrophysiol 2012; 5(5):933-40.
Steinberg C, Pelletier MJ, Perron J, Kumar A, Champagne J. Sudden Cardiac Arrest Due to Subtotal Absence of Left-sided Pericardium-Case Report and Review of the Literature.. Congenit Heart Dis 2013; 8(3):E92-8.
Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, Nault I, Blier L, Nadeau M, Charbonneau L, Trottier M, O'Hara G. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.. J Am Coll Cardiol 2012; 59(18):1616-25.
Parkash R, Exner D, Champagne J, Mangat I, Thibault B, Healey JS, Tung S, Crystal E, Simpson C, Nery PB, Sterns L, Connors S, Cameron D, Verma A, Beardsall M, Wolfe K, Essebag V, Ayala-Paredes F, Sanatani S, Coutu B, Fraser J, Toal S, Philippon F, Tang AS, Yee R, Krahn A.. Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.. Heart Rhythm 2013; 10(5):692-5.
Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN.. Reply to the Letters to the Editor Re: Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front STOP AF Pivotal Trial.. J Am Coll Cardiol 2013; 62(14):1307-8.
Urena M, Rodés-Cabau J, Freixa X, Saw J, Webb JG, Freeman M, Horlick E, Osten M, Chan A, Marquis JF, Champagne J, Ibrahim R.. Percutaneous Left Atrial Appendage Closure with the Amplatzer Cardiac Plug Device in Patients with Non-Valvular Atrial Fibrillation and Contraindications for Anticoagulation Therapy.. J Am Coll Cardiol 2013; 62(2):96-102.
Bennett MT, Ha AC, Exner DV, Tung SK, Parkash R, Connors S, Coutu B, Crystal E, Champagne J, Philippon F, Yee R, Stephenson EA, Nery PB, Essebag V, Sanatani S, Redfearn D, Krahn AD, Healey JS. The Canadian experience with Durata and Riata ST Optim defibrillator leads: A report from the Canadian Heart Rhythm Society Device Committee.. Heart Rhythm 2013; 10(10):1478-81.
Nault I, Champagne J.. How safe is ajmaline challenge in patients with suspected Brugada syndrome?. Heart Rhythm 2013; 10(12):1875-6.
Steinberg C, Sarrazin JF, Philippon F, Champagne J, Molin F, Nault I, Blier L, Bouchard MA, Arsenault J, O'Hara G.. PA/Lateral Chest X-Ray is Equivalent to Cine-Fluoroscopy for the Detection of Conductor Externalization in Defibrillation Leads.. Pacing Clin Electrophysiol 2015; 38(1):77-83.
Nair KK, Shurrab M, Skanes A, Danon A, Birnie D, Morillo C, Chauhan V, Mangat I, Ayala-Paredes F, Champagne J, Nault I, Tang A, Verma A, Lashevsky I, Singh SM, Crystal E. The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience.. J Interv Card Electrophysiol 2014; 39(2):139-44.
Vittoria Matassini M, Krahn AD, Gardner M, Champagne J, Sanatani S, Birnie DH, Gollob MH, Chauhan V, Simpson CS, Hamilton RM, Talajic M, Ahmad K, Gerull B, Chakrabarti S, Healey JS. Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia.. Heart Rhythm 2014; 11(2):274-81.
Somani R, Krahn AD, Healey JS, Chauhan VS, Birnie DH, Champagne J, Sanatani S, Angaran P, Gow RM, Chakrabarti S, Gerull B, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Klein GJ, Gollob MH, Talajic M, Gardner M, Simpson CS. Procainamide infusion in the evaluation of unexplained cardiac arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER).. Heart Rhythm 2014; 11(6):1047-54.
Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.. JAMA 2014; 311(7):692-700.
Michowitz Y, Rahkovich M, Oral H, Zado ES, Tilz R, John S, Denis A, Di Biase L, Winkle RA, Mikhaylov EN, Ruskin JN, Yao Y, Josephson ME, Tanner H, Miller JM, Champagne J, Della Bella P, Kumagai K, Defaye P, Luria D, Lebedev DS, Natale A, Jais P, Hindricks G, Kuck KH, Marchlinski FE, Morady F, Belhassen B. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures.. Circ Arrhythm Electrophysiol 2014; 7(2):274-80.
Verma A, Sanders P, Champagne J, Macle L, Nair GM, Calkins H, Wilber DJ. Selective complex fractionated atrial electrograms targeting for atrial fibrillation study (SELECT AF): a multicenter, randomized trial.. Circ Arrhythm Electrophysiol 2014; 7(1):55-62.
Steinberg C, Sarrazin JF, Philippon F, Champagne J, Bouchard MA, Molin F, Nault I, Blier L, O'Hara G.. Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure.. J Interv Card Electrophysiol 2014; 41(3):217-22.
Perrin MJ, Adler A, Green S, Al-Zoughool F, Doroshenko P, Orr N, Uppal S, Healey JS, Birnie D, Sanatani S, Gardner M, Champagne J, Simpson C, Ahmad K, van den Berg MP, Chauhan V, Backx PH, van Tintelen JP, Krahn AD, Gollob MH. Evaluation of genes encoding for the transient outward current (Ito) identifies the KCND2 gene as a cause of J-wave syndrome associated with sudden cardiac death.. Circ Cardiovasc Genet 2014; 7(6):782-9.
Parkash R, Tung S, Champagne J, Healey JS, Thibault B, Cameron D, Tang A, Connors S, Beardsall M, Mangat I, Ayala-Paredes F, Toal S, Exner D, Yee R, Krahn AD. Insight into the mechanism of failure of the Riata lead under advisory.. Heart Rhythm 2015; 12(3):574-9.
Nadeau PL, Philippon F, Sarrazin JF, Champagne J. A New Riata Lead Complication: Spontaneous Lead Tip Embolization.. J Cardiovasc Electrophysiol 2016; 27(2):234-5.
Nadeau PL, Champagne J, Molin F, Sarrazin JF, O'Hara G, Nault I, Blier L, Charbonneau É, Jacques F, Philippon F. Extra-anatomic Course of a Right Ventricular Pacing Lead: Clinical Implications.. Can J Cardiol 2015; 0(0):Epub.
Sroubek J, Probst V, Mazzanti A, Delise P, Hevia JC, Ohkubo K, Zorzi A, Champagne J, Kostopoulou A, Yin X, Napolitano C, Milan DJ, Wilde A, Sacher F, Borggrefe M, Ellinor PT, Theodorakis G, Nault I, Corrado D, Watanabe I, Antzelevitch C, Allocca G, Priori SG, Lubitz SA. Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.. Circulation 2016; 133(7):622-30.
Herman AR, Cheung C, Gerull B, Simpson CS, Birnie DH, Klein GJ, Champagne J, Healey JS, Gibbs K, Talajic M, Gardner M, Bennett MT, Steinberg C, Janzen M, Gollob MH, Angaran P, Yee R, Leather R, Chakrabarti S, Sanatani S, Chauhan VS, Krahn AD. Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.. Circ Arrhythm Electrophysiol 2016; 9(1):e003619.
Rodriguez-Gabella T, Nombela-Franco L, Regueiro A, Jiménez-Quevedo P, Champagne J, O'Hara G, Bernier M, Macaya C, Rodés-Cabau J. Single Antiplatelet Therapy Following Left Atrial Appendage Closure in Patients With Contraindication to Anticoagulation.. J Am Coll Cardiol 2016; 68(17):1920-1921.
Steinberg C, Padfield GJ, Champagne J, Sanatani S, Angaran P, Andrade JG, Roberts JD, Healey JS, Chauhan VS, Birnie DH, Janzen M, Gerull B, Klein GJ, Leather R, Simpson CS, Seifer C, Talajic M, Gardner M, Krahn AD. Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.. Circ Arrhythm Electrophysiol 2016; 9(9):e004274.
Herman AR, Cheung C, Gerull B, Simpson CS, Birnie DH, Klein GJ, Champagne J, Healey JS, Gibbs K, Talajic M, Gardner M, Bennett MT, Steinberg C, Janzen M, Gollob MH, Angaran P, Yee R, Leather R, Chakrabarti S, Sanatani S, Chauhan VS, Krahn AD. Response to Letter Regarding Article, "Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry".. Circ Arrhythm Electrophysiol 2016; 9(4):e004012.
Mellor G, Laksman ZWM, Tadros R, Roberts JD, Gerull B, Simpson CS, Klein GJ, Champagne J, Talajic M, Gardner M, Steinberg C, Arbour L, Birnie DH, Angaran P, Leather R, Sanatani S, Chauhan VS, Seifer C, Healey JS, Krahn AD. Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry).. Circ Cardiovasc Genet 2017; 10(3):e001686.
Rodés-Cabau J, O'Hara G, Paradis JM, Bernier M, Rodriguez-Gabella T, Regueiro A, O'Connor K, Beaudoin J, Puri R, Côté M, Champagne J. Changes in Coagulation and Platelet Activation Markers Following Transcatheter Left Atrial Appendage Closure.. Am J Cardiol 2017; 120(1):87-91.
Regueiro A, Bernier M, O'Hara G, O'Connor K, Paradis JM, Beaudoin J, Rodriguez-Gabella T, Champagne J, Rodés-Cabau J.. Left atrial appendage closure: Initial experience with the ultraseal device.. Catheter Cardiovasc Interv 2017; 90(5):817-23.
Andrade JG, Deyell MW, Badra M, Champagne J, Dubuc M, Leong-Sit P, Macle L, Novak P, Roux JF, Sapp J, Tang A, Verma A, Wells GA, Khairy P. Randomised clinical trial of cryoballoon versus irrigated radio frequency catheter ablation for atrial fibrillation-the effect of double short versus standard exposure cryoablation duration during pulmonary vein isolation (CIRCA-DOSE): methods and rationale.. BMJ Open 2017; 7(10):e017970.
Milman A, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Maeda S, Takahashi Y, Kamakura T, Aiba T, Conte G, Juang JJM, Leshem E, Rahkovich M, Hochstadt A, Mizusawa Y, Postema PG, Arbelo E, Huang Z, Denjoy I, Giustetto C, Wijeyeratne YD, Napolitano C, Michowitz Y, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Sarquella-Brugada G, Tfelt-Hansen J, Priori SG, Takagi M, Veltmann C, Delise P, Corrado D, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients.. Circ Arrhythm Electrophysiol 2017; 10(12):e005222.
Regueiro A, Cruz-Gonzalez I, Bethencourt A, Nombela-Franco L, Champagne J, Asmarats L, Jiménez-Quevedo P, Rodriguez-Gabella T, Rama-Merchan JC, Puri R, O'Hara G, Rodés-Cabau J. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.. J Interv Card Electrophysiol 2018; 52(1):53-9.
Conti S, Weerasooriya R, Novak P, Champagne J, Lim HE, Macle L, Khaykin Y, Pantano A, Verma A. Contact force sensing for ablation of persistent atrial fibrillation: A randomized, multicenter trial.. Heart Rhythm 2018; 15(2):201-208.
Milman A, Andorin A, Gourraud JB, Postema PG, Sacher F, Mabo P, Kim SH, Juang JJM, Maeda S, Takahashi Y, Kamakura T, Aiba T, Conte G, Sarquella-Brugada G, Leshem E, Rahkovich M, Hochstadt A, Mizusawa Y, Arbelo E, Huang Z, Denjoy I, Giustetto C, Wijeyeratne YD, Napolitano C, Michowitz Y, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Tfelt-Hansen J, Priori SG, Takagi M, Veltmann C, Delise P, Corrado D, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: Data from the Survey on Arrhythmic Events in BRUgada Syndrome.. Heart Rhythm 2018; 15(5):716-24.
Verma A, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, Sharma M, Wyse DG, Champagne J, Essebag V, Wells G, Gupta D, Heidbuchel H, Sanders P, Birnie DH. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.. Am Heart J 2018; 197(0):124-132.
Michowitz Y, Milman A, Sarquella-Brugada G, Andorin A, Champagne J, Postema PG, Casado-Arroyo R, Leshem E, Juang JJM, Giustetto C, Tfelt-Hansen J, Wijeyeratne YD, Veltmann C, Corrado D, Kim SH, Delise P, Maeda S, Gourraud JB, Sacher F, Mabo P, Takahashi Y, Kamakura T, Aiba T, Conte G, Hochstadt A, Mizusawa Y, Rahkovich M, Arbelo E, Huang Z, Denjoy I, Napolitano C, Brugada R, Calo L, Priori SG, Takagi M, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome.. Heart Rhythm 2018; 15(9):1394-1401.
Gitenay E, Molin F, Blais S, Tremblay V, Gervais P, Plourde B, Jacques F, Steinberg C, Sarrazin JF, Charbonneau É, Parent H, O'Hara GE, Champagne J, Philippon F. Cardiac Implantable Electronic Device Infection: Detailed Analysis of Cost Implications.. Can J Cardiol 2018; 34(8):1026-1032.
Asmarats L, Bernier M, O'Hara G, Paradis JM, O'Connor K, Beaudoin J, Bilodeau S, Cavalcanti R, Champagne J, Rodés-Cabau J. Hemodynamic impact of percutaneous left atrial appendage closure in patients with paroxysmal atrial fibrillation.. J Interv Card Electrophysiol 2018; 53(2):151-157.
Sarrazin JF, Philippon F, Sellier R, André P, O'Hara G, Molin F, Nault I, Blier L, Champagne J. Clinical performance of different DF-4 implantable cardioverter defibrillator leads.. Pacing Clin Electrophysiol 2018; 0(0):Epub.
André P, Plourde B, Molin F, Sarrazin JF, Champagne J, Philippon F. T-wave oversensing due to left ventricle-only pacing in cardiac resynchronization therapy optimization algorithm.. HeartRhythm Case Rep 2018; 4(9):401-404.
Milman A, Hochstadt A, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Conte G, Arbelo E, Kamakura T, Aiba T, Napolitano C, Giustetto C, Denjoy I, Juang JJM, Maeda S, Takahashi Y, Leshem E, Michowitz Y, Rahkovich M, Jespersen CH, Wijeyeratne YD, Champagne J, Calo L, Huang Z, Mizusawa Y, Postema PG, Brugada R, Wilde AAM, Yan GX, Behr ER, Tfelt-Hansen J, Hirao K, Veltmann C, Leenhardt A, Corrado D, Gaita F, Priori SG, Kusano KF, Takagi M, Delise P, Brugada J, Brugada P, Nam GB, Probst V, Belhassen B. Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).. Europace 2019; 21(5):796-802.
Malhi N, So PP, Cheung CC, Laksman ZWM, Healey JS, Chauhan VS, Green MS, Champagne J, Steinberg C, Sanatani S, Angaran P, Duff H, Roberts JD, Arbour L, Leather R, Simpson CS, Tadros R, Talajic M, Gardner M, Siefer C, Krahn AD. Early Repolarization Pattern Inheritance in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER).. JACC Clin Electrophysiol 2018; 4(11):1473-1479.
Andrade JG, Champagne J, Deyell MW, Essebag V, Lauck S, Morillo C, Sapp J, Skanes A, Theoret-Patrick P, Wells GA, Verma A. A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.. Am Heart J 2018; 206(0):94-104.
Nault I, André P, Plourde B, Leclerc F, Sarrazin JF, Philippon F, O'Hara G, Molin F, Steinberg C, Roy K, Blier L, Champagne J. Validation of a novel single lead ambulatory ECG monitor - Cardiostat? - Compared to a standard ECG Holter monitoring.. J Electrocardiol 2018; 53(0):57-63.
Cheung CC, Mellor G, Deyell MW, Ensam B, Batchvarov V, Papadakis M, Roberts JD, Leather R, Sanatani S, Healey JS, Chauhan VS, Birnie DH, Champagne J, Angaran P, Klein GJ, Yee R, Simpson CS, Talajic M, Gardner M, Yeung-Lai-Wah JA, Chakrabarti S, Laksman ZW, Sharma S, Behr ER, Krahn AD.. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.. JACC Clin Electrophysiol 2019; 5(4):504-512.
Knight BP, Novak PG, Sangrigoli R, Champagne J, Dubuc M, Adler SW, Svinarich JT, Essebag V, Hokanson R, Kueffer F, Jain SK, John RM, Mansour M; STOP AF PAS Investigators.. Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study.. JACC Clin Electrophysiol 2019; 5(3):306-314.
Michowitz Y, Milman A, Andorin A, Sarquella-Brugada G, Gonzalez Corcia MC, Gourraud JB, Conte G, Sacher F, Juang JJM, Kim SH, Leshem E, Mabo P, Postema PG, Hochstadt A, Wijeyeratne YD, Denjoy I, Giustetto C, Mizusawa Y, Huang Z, Jespersen CH, Maeda S, Takahashi Y, Kamakura T, Aiba T, Arbelo E, Mazzanti A, Allocca G, Brugada R, Casado-Arroyo R, Champagne J, Priori SG, Veltmann C, Delise P, Corrado D, Brugada J, Kusano KF, Hirao K, Calo L, Takagi M, Tfelt-Hansen J, Yan GX, Gaita F, Leenhardt A, Behr ER, Wilde AAM, Nam GB, Brugada P, Probst V, Belhassen B.. Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.. J Am Coll Cardiol 2019; 73(14):1756-1765.
Steinberg C, Philippon F, Sanchez M, Fortier-Poisson P, O'Hara G, Molin F, Sarrazin JF, Nault I, Blier L, Roy K, Plourde B, Champagne J. A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality.. Biosensors (Basel) 2019; 9(1):E17.
Milman A, Gourraud JB, Andorin A, Postema PG, Sacher F, Mabo P, Conte G, Giustetto C, Sarquella-Brugada G, Hochstadt A, Kim SH, Juang JJM, Maeda S, Takahashi Y, Kamakura T, Aiba T, Leshem E, Michowitz Y, Rahkovich M, Mizusawa Y, Arbelo E, Huang Z, Denjoy I, Wijeyeratne YD, Napolitano C, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Tfelt-Hansen J, Priori SG, Takagi M, Veltmann C, Delise P, Corrado D, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B.. Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients.. Heart Rhythm 2018; 15(10):1457-1465.
Nault I, André P, Plourde B, Leclerc F, Sarrazin JF, Philippon F, O'Hara G, Molin F, Steinberg C, Roy K, Blier L, Champagne J. Validation of a novel single lead ambulatory ECG monitor - Cardiostat? - Compared to a standard ECG Holter monitoring.. J Electrocardiol 2019; 53(0):57-63.
Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Mangat I, Khoo C, Steinberg C, Bennett MT, Tang ASL, Khairy P (Sarrazin JF parmi les 24 collaborateurs). Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.. Circulation 2019; 140(22):1779-1788.
Steinberg C, Philippon F, O'Hara G, Champagne J. Orthodromic atrioventricular reentrant tachycardia using a concealed isoproterenol-sensitive accessory pathway.. Indian Pacing Electrophysiol J 2020; 20(2):73-77.
Freitas-Ferraz AB, Rodés-Cabau J, Junquera Vega L, Beaudoin J, O'Connor K, Turgeon PY, Paradis JM, Ferreira-Neto A, Asmarats L, Champagne J, O'Hara G, Bernier M. Transesophageal echocardiography complications associated with interventional cardiology procedures.. Am Heart J 2020; 221(0):19-28.
Jain SK, Novak PG, Sangrigoli R, Champagne J, Dubuc M, Adler SW, Svinarich JT, Essebag V, Martien M, Anderson C, John RM, Mansour M, Knight BP. Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation: Results from the STOP-AF Post-Approval Study.. Heart Rhythm 2020; 17(3):485-491.
Milman A, Andorin A, Postema PG, Gourraud JB, Sacher F, Mabo P, Kim SH, Maeda S, Takahashi Y, Kamakura T, Aiba T, Conte G, Juang JJM, Leshem E, Michowitz Y, Fogelman R, Hochstadt A, Mizusawa Y, Giustetto C, Arbelo E, Huang Z, Corrado D, Delise P, Allocca G, Takagi M, Wijeyeratne YD, Mazzanti A, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Sarquella-Brugada G, Jespersen CH, Tfelt-Hansen J, Veltmann C, Priori SG, Behr ER, Yan GX, Brugada J, Gaita F, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome.. Heart Rhythm 2019; 16(10):1468-1474.
Andrade JG, Deyell MW, Nattel S, Khairy P, Dubuc M, Champagne J, Leong-Sit P, Jolly U, Badra M, Sapp J, Verma A, Macle L. Prevalence and clinical impact of spontaneous and adenosine-induced pulmonary vein reconduction in the Contact-Force vs. Cryoballoon Atrial Fibrillation Ablation (CIRCA-DOSE) Study.. Heart Rhythm 2020; 17(6):897-904.
Steinberg C, Nadeau-Routhier C, André P, Philippon F, Sarrazin JF, Nault I, O'Hara G, Blier L, Molin F, Plourde B, Roy K, Larose E, Arsenault M, Champagne J. Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience.. Front Cardiovasc Med 2020; 7(0):548564.
Asmarats L, O'Hara G, Champagne J, Paradis JM, Bernier M, O'Connor K, Beaudoin J, Junquera L, Del Val D, Muntané-Carol G, Côté M, Rodés-Cabau J. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.. Circ Cardiovasc Interv 2020; 13(8):e009039.
Freitas-Ferraz AB, Bernier M, Vaillancourt R, Ugalde Figueroa PA, Nicodème F, Paradis JM, Champagne J, O'Hara G, Junquera L, Del Val D, Muntané-Carol G, O'Connor K, Beaudoin J, Rodés-Cabau J. Safety of Transesophageal Echocardiography to Guide Structural Cardiac Interventions.. J Am Coll Cardiol 2020; 75(25):3164-3173.
De Larochellière H, Champagne J, Sarrazin JF, Steinberg C, Philippon F, Roy K, Molin F, O'Hara G, Plourde B, Blier L, Nault I. Findings of remote monitoring of implantable cardioverter defibrillators during the COVID-19 pandemic.. Pacing Clin Electrophysiol 2020; 43(11):1366-1372.
Steinberg C, Cheung CC, Wan D, Sodhi A, Claros S, Staples JA, Philippon F, Laksman Z, Sarrazin JF, Bennett M, Plourde B, Deyell MW, Andrade JG, Roy K, Yeung-Lai-Wah JA, Molin F, Hawkins NM, Blier L, Nault I, O'Hara G, Krahn AD, Champagne J, Chakrabarti S. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study.. Can J Cardiol 2020; 36(8):1269-1277.
Philippon F, O'Hara GE, Champagne J, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, Gadler F, Lashevsky N, Connolly SJ, Liu YY, Healey JS. Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial.. CJC Open 2020; 2(5):354-359.
Andrade JG, Macle L, Verma A, Deyell MW, Champagne J, Dubuc M, Leong-Sit P, Novak P, Roux JF, Sapp J, Khoo C, Rizkallah J, Levesque S, Tang ASL, Khairy P. Quality of Life and Health Care Utilization in the CIRCA-DOSE Study.. JACC Clin Electrophysiol 2020; 6(8):935-944.
Cheung CC, Deyell MW, Macle L, Verma A, Champagne J, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Khairy P, Andrade JG. Repeat Atrial Fibrillation Ablation Procedures in the CIRCA-DOSE Study.. Circ Arrhythm Electrophysiol 2020; 13(9):e008480.
Larsen JM, Deyell MW, Macle L, Champagne J, Sarrazin JF, Leong-Sit P, Badra-Verdu M, Sapp J, Khairy P, Andrade JG. Impact of Left Common Pulmonary Veins in the Contact-Force vs. Cryoballoon Atrial Fibrillation Ablation (CIRCA-DOSE) Study.. J Cardiovasc Electrophysiol 2020; 0(0):Epub.
Andrade JG, Deyell MW, Verma A, Macle L, Champagne J, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Khairy P, Nattel S. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.. JAMA Netw Open 2020; 3(7):e208748.
Su WW, Reddy VY, Bhasin K, Champagne J, Sangrigoli RM, Braegelmann KM, Kueffer FJ, Novak P, Gupta SK, Yamane T, Calkins H. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial.. Heart Rhythm 2020; 17(11):1841-1847.
Steinberg C, Dognin N, Sodhi A, Champagne C, Staples JA, Champagne J, Laksman Z, Sarrazin JF, Bennett M, Plourde B, Deyell MW, Andrade JG, Roy K, Yeung-Lai-Wah JA, Hawkins NM, Mondésert B, Blier L, Nault I, O'Hara G, Krahn AD, Philippon F, Chakrabarti S. DREAM-ICD-II study.. Circulation 2022; 145(10):742-753.
Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Macle L, Verma A; EARLY-AF Investigators (Champagne J, Nault I, Sarrazin JF, Philippon F, O'Hara G, Molin F, Blier L, Plourde B, Roy K, Steinberg C parmi les collaborateurs).. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.. N Engl J Med 2021; 384(4):305-315.
Freitas-Ferraz AB, Bernier M, O'Connor K, Beaudoin J, Champagne J, Paradis JM, O'Hara G, Muntané-Carol G, Alperi A, Faroux L, Junquera L, Rodés-Cabau J. Safety and effects of volume loading during transesophageal echocardiography in the pre-procedural work-up for left atrial appendage closure.. Cardiovasc Ultrasound 2021; 19(1):3.
Salaun E, Conde IS, O'Connor K, Beaudoin J, Bernier F, O'Hara G, Champagne J, Paradis JM, Dognin N, Lemyre M, Rodes-Cabau J, Bernier M. Billowing Motion of the Polyester Fabric Cover With WATCHMAN FLX Device: The Wind Sailing Effect.. JACC Cardiovasc Interv 2021; 14(16):e201-e204.
Steinberg C, Pilote S, Philippon F, Laksman ZW, Champagne J, Simard C, Krahn AD, Drolet B. SCN5A-C683R exhibits combined gain-of-function and loss-of-function properties related to adrenaline-triggered ventricular arrhythmia.. Exp Physiol 2021; 106(3):683-699.
Champagne C, Dognin N, Molin F, Steinberg C, Philippon F, Sarrazin JF, O'Hara G, Nault I, Roy K, Plourde B, Blier L, Champagne J. Twiddler Syndrome without Lead Dislodgment Discovered by Remote Monitoring.. Case Rep Cardiol 2021; 2021(0):8816524.
Verma A, Wells G, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, Sharma M, Champagne J, Essebag V, Heidbuchel H, Sanders P, Birnie DH. OCEAN Trial Update.. Am Heart J 2022; 248(0):169.
Samuel M, Khairy P, Champagne J, Deyell MW, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Tardif JC, Andrade JG. Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.. JAMA Cardiol 2021; 0(0):e213063.
Steinberg C, Champagne J, Deyell MW, Dubuc M, Leong-Sit P, Calkins H, Sterns L, Badra-Verdu M, Sapp J, Macle L, Khairy P, Andrade JG. Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study.. Heart Rhythm 2021; 18(9):1463-1470.
Champagne C, Dognin N, Rodés-Cabau J, Champagne J. Left atrial appendage perforation during appendage angiography treated by percutaneous left atrial appendage closure: a case report.. Eur Heart J Case Rep 2021; 5(5):ytab187.
Dognin N, Salaun E, Champagne C, Domain G, O'Hara G, Philippon F, Paradis JM, Faroux L, Beaudoin J, O'Connor K, Bernier M, Rodés-Cabau J, Champagne J. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.. J Interv Card Electrophysiol 2022; 64(2):497-509.
Silva I, Beaudoin J, Champagne J, Paradis JM, Bernier M, O'Connor K, Dognin N, Lemyre M, Rodes-Cabau J, O'Hara G, Salaun E. Post-release shift with Watchman FLX devices during left atrial appendage closure: the "popcorn effect".. EuroIntervention 2022; 18(2):e181-e182.
Philippon F, Domain G, Sarrazin JF, Nault I, O'Hara G, Champagne J, Steinberg C. Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts.. Can J Cardiol 2022; 38(4):515-525.
Domain G, Dognin N, O'Hara G, Rodès-Cabau J, Paradis JM, Strubé C, Bernier M, O'Connor K, Beaudoin J, Philippon F, Salaun E, Champagne J. Experience of Combined Procedure during Percutaneous LAA Closure.. J Clin Med 2022; 11(12):3280.
Salaun E, Bernier M, Paradis JM, Champagne J, Silva Conde I, Beaudoin J, O'Connor K, Dognin N, Alperi A, Mesnier J, Panagides V, Lemyre M, Rodes-Cabau J, O'Hara G. Watchman 2.5^TM versus Watchman FLX^TM device in atypical left atrial anatomies: old fashion never dies.. Acta Cardiol 2023; 78(3):372-376.
Sarrazin JF, Laaouaj J, Philippon F, Sanchez M, Gervais P, Champagne J, Steinberg C, Nault I, Roy K, Plourde B, Blier L, O'Hara G. Safety of Cefazolin Test Dose in Patients With Penicillin Allergy Just Prior to Cardiac Device Implantation: A Single-Centre Experience.. CJC Open 2022; 4(8):695-700.
Andrade JG, Macle L, Bennett MT, Hawkins NM, Essebag V, Champagne J, Roux JF, Makanjee B, Tang A, Skanes A, Khaykin Y, Morillo C, Jolly U, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Wells GA, Verma A, Deyell MW. Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial.. J Interv Card Electrophysiol 2022; 65(2):481-489.
Milman A, Sabbag A, Conte G, Postema PG, Andorin A, Gourraud JB, Sacher F, Mabo P, Kim SH, Maeda S, Takahashi Y, Kamakura T, Aiba T, Juang JJ, Michowitz Y, Leshem E, Mizusawa Y, Arbelo E, Huang Z, Denjoy I, Giustetto C, Wijeyeratne YD, Mazzanti A, Brugada R, Casado-Arroyo R, Champagne J, Calo L, Sarquella-Brugada G, Tfelt-Hansen J, Priori SG, Takagi M, Veltmann C, Delise P, Corrado D, Behr ER, Gaita F, Yan GX, Brugada J, Leenhardt A, Wilde AAM, Brugada P, Kusano KF, Hirao K, Nam GB, Probst V, Belhassen B. Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS.. Circ Arrhythm Electrophysiol 2023; 0(0):e011360.
Georges G, Philippon F, Champagne J, Albert E, O'Hara GE. Leadless Pacemaker Implantation in a Patient With Hypoplasia of the Left Brachiocephalic Vein.. CJC Open 2022; 4(9):810-812.
Gaudreault N, Ruel LJ, Henry C, Schleit J, Lagüe P, Champagne J, Sénéchal M, Sarrazin JF, Philippon F, Bossé Y, Steinberg C.. Novel filamin C (FLNC) variant causes a severe form of familial mixed hypertrophic-restrictive cardiomyopathy.. Am J Med Genet A 2023; 191(6):1508-1517.
Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Cadrin-Tourigny J, Kochhäuser S, Verma A. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.. N Engl J Med 2023; 388(2):105-116.
Nuche J, Masso van-Roessel A, Nault I, Paradis JM, de Larochellière R, Mesnier J, Champagne J, Mohammadi S, Philippon F, Rodés-Cabau J. Temporary active fixation lead pacemaker in transcatheter aortic valve replacement patients with right bundle branch block.. Heart Rhythm 2023; 20(2):309-310.
Steinberg C, Gaudreault N, Papadakis AI, Henry C, Champagne J, Philippon F, O'Hara G, Blier L, Plourde B, Nault I, Roy K, Sarrazin JF, Spatz A, Bossé Y. Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome.. Europace 2023; 25(6):euad145.
Andrade JG, Deyell MW, Khairy P, Champagne J, Leong-Sit P, Novak P, Sterns L, Roux JF, Sapp J, Bennett R, Bennett M, Hawkins N, Sanders P, Macle L. Atrial fibrillation progression after cryoablation versus radiofrequency ablation: the CIRCA-DOSE trial.. Eur Heart J 2023; 0(0):ehad572.
Joza J, Nair GM, Birnie DH, Nery PB, Redpath CJ, Sarrazin JF, Champagne J, Bernick J, Wells GA, Essebag V. High-power short-duration versus low-power long-duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial.. J Cardiovasc Electrophysiol 2023; 0(0):Epub.

Dr Jean Champagne

Domaine de recherche

Description des travaux

Prix et distinctions

Publications

Soutenir la médecine de demain, maintenant.

Soutenir la médecine
de demain, maintenant.